FLORA-5/GOG3035: Chemo-immunotherapy (paclitaxel-carboplatin-oregovomab [PCO] vs chemotherapy (paclitaxel-carboplatin-placebo [PCP]) as front-line treatment in patients with advanced epithelial ...
Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial Participants were adults with advanced ...
Quantitative and qualitative approaches face different challenges and expectations, particularly when it comes to data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results